Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
According to new survey data, nonadherence is not for lack of concern about the disease—75% of the women surveyed reported being concerned about their breast health.
Currently, there is no standardized reporting requirement related to BACs, and ACR classifies reporting vascular calcifications on breast imaging as optional.
Digital breast tomosythesis now makes up close to 50% of mammography systems in the U.S. "Tomo is going to replace just straight digital mammography simply because of the benefit of fewer recalls," explained Debra L. Monticciolo, MD.
Debra L. Monticciolo, MD, past president of both the Society of Breast Imaging and the American College of Radiology, explains the advantages and disadvantages of current breast screening technology.
Pedro Martinez-Clark, MD, an interventional cardiologist and founder of Amavita Heart and Vascular Health, explains the health disparities he encounters that block the delivery of care in certain parts of Miami.